The Cannabis Act legalized the possession and sale of nonmedical cannabis in Canada on October 17, 2018. Evaluating the impact of cannabis legalization requires a more thorough understanding than is provided by most existing measures of cannabis use. The aim of this study was to pretest a range of cannabis consumption measures used in a population-based survey and to share insights gained in the process. Cognitive interviewing was conducted among 10 cannabis users aged ≥16 years. Comprehension and self-reporting of consumption types and amounts, sources of purchase, and cannabinoid levels were examined. Findings revealed areas for improvement in a number of survey items, including unclear wording and reference images. Identified issues were used to improve the survey for use in the International Cannabis Policy Study. The authors discuss important principles (e.g., use of visual cues, user-selected units, and time frames) that should be adopted when assessing cannabis use in population-based studies.
BarrusD. G.CapogrossiK. L.CatesS. C.GourdetC. K.PeiperN. C.NovakS. P.LefeverT. W.WileyJ. L. (2016). Tasty THC: Promises and Challenges of Cannabis Edibles. Methods report (RTI Press), 2016, 10.3768/rtipress.2016.op.0035.1611.
3.
BorodovskyJ. T.CrosierB. S.LeeD. C.SargentJ. D.BudneyA. J. (2016). Smoking, vaping, eating: Is legalization impacting the way people use cannabis?International Journal of Drug Policy, 36, 141–147. doi:10.1016/j.drugpo.2016.02.022
4.
BottorffJ. L.BissellL. J. L.BalneavesL. G.OliffeJ. L.CaplerN. R.BuxtonJ. (2013). Perceptions of cannabis as a stigmatized medicine: A qualitative descriptive study. Harm Reduction Journal, 10, Article 2. doi:10.1186/1477-7517-10-2
CuttlerC.SpradlinA. (2017). Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU). PLoS ONE, 12(5), e0178194. doi:10.1371/journal.pone.0178194
7.
GhoshT. S.VigilD. I.MaffeyA.TolliverR.Van DykeM.KattariL.. . . WolkL. (2017). Lessons learned after three years of legalized, recreational marijuana: The Colorado experience. Preventive Medicine, 104, 4–6. doi:10.1016/j.ypmed.2017.02.021
HamiltonH. A.BrandsB.IalomiteanuA. R.MannR. E. (2017). Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada. Canadian Journal of Public Health, 108, e282–e287. doi:10.17269/CJPH.108.6130
11.
HammondD.GoodmanS.Leos-ToroC.WadsworthE.ReidJ. L.HallW.. . . ElliotR. (2018). International Cannabis Policy Study Wave 1 Survey. Retrieved from http://cannabisproject.ca/methods/
MurphyM.HollinghurstS.SalisburyC. (2018). Qualitative assessment of the Primary Care Outcomes Questionnaire: A cognitive interview study. BMC Health Services Research, 18, Article 79. doi:10.1186/s12913-018-2867-6
16.
National Academies of Sciences, Engineering, and Medicine. (2017). Chapter 4: Therapeutic effects of cannabis and cannabinoids. In The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research (Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda). Washington, DC: The National Academies Press. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK425767/
17.
National Academies of Sciences, Engineering, and Medicine. (2015). Chapter 4: Measuring the size of the illicit tobacco market. In ReuterP.MajmundarM. (Eds.), Understanding the U.S. illicit tobacco market: Characteristics, policy context, and lessons from international experiences (Committee on the Illicit Tobacco Market: Collection and Analysis of the International Experience, Committee on Law and Justice, Division of Behavioral and Social Sciences and Education. Board on Population Health and Public Health Practice, Institute of Medicine). Washington, DC: The National Academies Press. Retrieved from https://www.nap.edu/read/19016/chapter/6
18.
NewmeyerM. N.SwortwoodM. J.AbulseoudaO. A.HuestisaM. A. (2017). Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration. Drug and Alcohol Dependence, 175, 67–76. doi:10.1016/j.drugalcdep.2017.02.003
19.
Parliament of Canada. (2018). An act respecting cannabis and to amend the Controlled Drugs and Substances Act the Criminal Code and other Acts. In Senate. Bill C-45. Statues of Canada 2018. Retrieved from https://www.parl.ca/DocumentViewer/en/42-1/bill/C-45/royal-assent
RussellC.RuedaS.RoomR.TyndallM.FischerB. (2018). Routes of administration for cannabis use—Basic prevalence and related health outcomes: A scoping review and synthesis. International Journal of Drug Policy, 52, 87–96.
22.
SatterlundT. D.LeeJ. P.MooreR. S. (2015). Stigma among California’s medical marijuana patients. Journal of Psychoactive Drugs, 47, 10–17. doi:10.1080/02791072.2014.991858
23.
SolorioR.AyalaN. C.PaezE.SkalickyA. M.MoralesL. S. (2016). Use of cognitive interviews to adapt PROMIS measurement items for Spanish speakers living with HIV. AIDS Research and Treatment, 2016, Article 8340863. doi:10.1155/2016/8340863
24.
United Nations Office on Drugs and Crime. (2017). World drug report 2017 (ISBN: 978-92-1-148291-1, eISBN: 978-92-1-060623-3, United Nations publication, Sales No. E.17.XI.6). Retrieved from https://www.unodc.org/wdr2017/index.html
VaucherJ.KeatingB. J.LasserreA. M.GanW.LyallD. M.WardJ.. . . HolmesM. V. (2018). Cannabis use and risk of schizophrenia: A Mendelian randomization study. Molecular Psychiatry, 23, 1287–1292. doi:10.1038/mp.2016.252
27.
VolkowN. D.BalerR. D.ComptonW. M.WeissS. R. B. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370, 2219–2227.
28.
WillisG. B. (2005). Cognitive interviewing: A tool for improving questionnaire design. Thousand Oaks, CA: Sage. doi:10.4135/9781412983655
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
